Please be specific Dr._l. 1. How do you know the data was manipulated? 2. If there was data manipulation, how was it manipulated? 3. What was manipulated (e.g. the results generated by the treatment patients and/or the crossover patients)? 4. If the data was manipulated as a cover up for a failed trial, why is Dr. Liau getting ready to tell her audience next month at the SNO, that DCVax-L has efficacy for both ndGBM and rGBM patients? Is she being dishonest?
Market Data 
Markets 
AI
